Events

Videos

Podcasts

Articles

Clinical

® Clinical Focus page includes a listing of all specialities covered across  OncLive.com, including breast cancer, lung cancer, gastrointestinal cancers, genitourinary cancers, hematologic malignancies, and gynecologic cancers. Each individual specialty page features news articles, interviews in written and video format, and podcasts that focus on unmet needs, treatment advances in both the localized and metastatic settings, and ongoing research.


Adjuvant Everolimus and CDK4/6 Trials in Breast Cancer

Managing the Toxicity of Everolimus in Breast Cancer

Second-Line Everolimus in Metastatic Breast Cancer

Frontline Treatment of ER-Positive Breast Cancer

T-DM1 Plus Pertuzumab in the MARIANNE Trial

Fitting T-DM1 Into Established Upfront Treatment Paradigms

Utilizing pCR in Breast Cancer Trials

Upfront T-DM1 in HER2-Positive Breast Cancer

HER2 Testing Challenges in Metastatic Breast Cancer

First-Line Treatment of HER2-Positive MBC

Exceptional Responders in Breast Cancer

Nab-Paclitaxel in Metastatic Breast Cancer

Introduction: Chemotherapies for Advanced Breast Cancer

Women harboring a loss-of-function mutation in the PALB2 gene demonstrated an increased risk of developing breast cancer that was similar to the predisposition seen with mutations in the infamous BRCA gene

PALB2, BRCA2 Gene Mutations Confer Similar Breast Cancer Risk

Sara Hurvitz, MD, medical oncologist, UCLA Medical Center, gives an overview of treatment hypotheses for triple-negative breast cancer (TNBC).

Dr. Hurvitz on Treatment Hypotheses for TNBC

Halle Moore, MD, medical oncologist, Cleveland Clinic, discusses the results of the phase III POEMS study, which was presented at the 2014 ASCO Annual Meeting.

Dr. Halle Moore Discusses Results of the Phase III POEMS Study in Breast Cancer

Evolving Therapeutic Landscape in Breast Cancer

Case Studies: Treating Metastatic Breast Cancer

Clinical Setting for Eribulin in Metastatic Breast Cancer

Treatment Strategies in ER-Positive Breast Cancer

HER2+ Breast Cancer

The OncLive Neoadjuvant HER2+ Cancer condition center page is a comprehensive resource for clinical news and expert insights on treatment for patients with HER2-positive breast cancer. This page features news articles, interviews in written and video format, and podcasts that focus on unmet needs, treatment advances in both the localized and metastatic settings, and ongoing research in HER2-positive breast cancer.

 Breast Cancer condition center page is a comprehensive resource for clinical news and expert insights on various types of breast cancer, including those that are triple negative, hormone receptor positive, and/or HER2 positive. This page features news articles, interviews in written and video format, and podcasts that focus on treatment advances and ongoing research in breast cancer.

Breast Cancer

Breast Cancer | Specialty